|
|
The scope of this event will be to explore new solutions, promising technology breakthroughs and how industry introduces and incorporates improved approaches in drug development. Our program includes an opening and closing keynote and several provocative and focused panel discussions demonstrating some of the approaches in improving ways to address complex formulation development and manufacturing methods of small molecule compounds. Within this scope, we will explore how biotech and pharma executives, consultants, CDMOs must work seamlessly together and how critical it is to invest their resources to meet the demands and expectations to develop high quality drug products. Since our event is designed to bring a focused group together to exchange ideas and experiences, there will be plenty of networking opportunities throughout the day.
